Published in PLoS One on February 06, 2015
Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia. Schizophr Bull (2015) 0.78
CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells. Mol Autism (2017) 0.75
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder. Transl Psychiatry (2015) 0.75
Knockdown of the schizophrenia susceptibility gene TCF4 alters gene expression and proliferation of progenitor cells from the developing human neocortex. J Psychiatry Neurosci (2016) 0.75
Cognitive endophenotypes inform genome-wide expression profiling in schizophrenia. Neuropsychology (2016) 0.75
The progress of early growth response factor 1 and leukemia. Intractable Rare Dis Res (2016) 0.75
Human dermal fibroblasts in psychiatry research. Neuroscience (2016) 0.75
The Role of Early Growth Response 1 (EGR1) in Brain Plasticity and Neuropsychiatric Disorders. Front Behav Neurosci (2017) 0.75
A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects. Front Pharmacol (2017) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52
Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics (2005) 10.64
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Spatio-temporal transcriptome of the human brain. Nature (2011) 9.19
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature (2011) 6.21
Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics (2009) 3.41
Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet (2006) 3.19
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
Permutation P-values should never be zero: calculating exact P-values when permutations are randomly drawn. Stat Appl Genet Mol Biol (2010) 2.13
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry (2012) 2.07
Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry (2009) 1.68
Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet (2010) 1.63
Towards understanding the schizophrenia code: an expanded convergent functional genomics approach. Am J Med Genet B Neuropsychiatr Genet (2007) 1.55
Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. Biol Psychiatry (2014) 1.54
Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci U S A (2007) 1.46
Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One (2010) 1.41
Control of the establishment of aversive memory by calcineurin and Zif268. Nat Neurosci (2008) 1.36
Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity. Biol Psychiatry (2014) 1.27
Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet (2005) 1.22
Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry (2010) 1.21
Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res (2013) 1.20
Modeling psychiatric disorders at the cellular and network levels. Mol Psychiatry (2012) 1.14
On the outside, looking in: a review and evaluation of the comparability of blood and brain "-omes". Am J Med Genet B Neuropsychiatr Genet (2013) 1.13
The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants. Mol Psychiatry (2012) 1.07
Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry (2012) 1.06
Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology? Schizophr Res (2014) 1.06
A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. J Psychiatr Res (2012) 1.02
Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative? PLoS One (2008) 1.02
Primary skin fibroblasts as a model of Parkinson's disease. Mol Neurobiol (2012) 1.01
Making memories of stressful events: a journey along epigenetic, gene transcription, and signaling pathways. Front Psychiatry (2014) 1.01
The emerging roles of TCF4 in disease and development. Trends Mol Med (2014) 0.99
Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research. Biol Psychiatry (2013) 0.98
TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders. Transl Psychiatry (2012) 0.97
Epigenetics and psychiatry. Neurotherapeutics (2013) 0.96
Finding the needle in the haystack: a review of microarray gene expression research into schizophrenia. Aust N Z J Psychiatry (2012) 0.95
Human fibroblast-derived cell lines have characteristics of embryonic stem cells and cells of neuro-ectodermal origin. Differentiation (2005) 0.93
The effect of chronological age on the inflammatory response of human fibroblasts. Exp Gerontol (2012) 0.92
Schizophrenia genetics: putting all the pieces together. Curr Neurol Neurosci Rep (2012) 0.92
TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease. Am J Med Genet B Neuropsychiatr Genet (2012) 0.91
Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine. J Psychiatr Res (2013) 0.90
Genome-wide approaches reveal EGR1-controlled regulatory networks associated with neurodegeneration. Neurobiol Dis (2013) 0.90
Epigenetics of schizophrenia. Curr Top Behav Neurosci (2010) 0.89
Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors. Stem Cells Transl Med (2013) 0.89
Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia. PLoS One (2012) 0.88
Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. J Proteome Res (2010) 0.88
Differential expression of mitogen-activated protein kinases and immediate early genes fos and jun in thalamus in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.88
Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res (2013) 0.87
Effects of pro-inflammatory cytokines on expression of kynurenine pathway enzymes in human dermal fibroblasts. J Inflamm (Lond) (2011) 0.87
Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients. J Psychiatr Res (2013) 0.86
Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients. Mol Psychiatry (2014) 0.85
Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology (2004) 0.85
Epigenetic regulations of immediate early genes expression involved in memory formation by the amyloid precursor protein of Alzheimer disease. PLoS One (2014) 0.84
The impact of heat shock protein 70 gene variations on clinical presentation and outcome in schizophrenic inpatients. Neuropsychobiology (2009) 0.83
The role of egr1 in early zebrafish retinogenesis. PLoS One (2013) 0.82
Metabolic stress-induced microRNA and mRNA expression profiles of human fibroblasts. Exp Cell Res (2013) 0.82
Time-course of immediate early gene expression in hippocampal subregions of adrenalectomized rats after acute corticosterone challenge. Brain Res (2008) 0.82
Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective. Cell Mol Life Sci (2014) 0.82
Increased expression of c-Jun transcription factor in cerebellar vermis of patients with schizophrenia. Neuropsychopharmacology (2003) 0.81
Impact of TCF4 on the genetics of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2011) 0.81
GABA(B) modulation of dopamine release in the nucleus accumbens core. Eur J Neurosci (2014) 0.79
F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum. Eur J Pharmacol (2009) 0.79
Neuroimmune biomarkers in schizophrenia. Schizophr Res (2014) 0.78
A simplified method to quantify dysregulated tyrosine transport in schizophrenia. Schizophr Res (2013) 0.76
Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia. Schizophr Res (2012) 0.76
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder. J Affect Disord (2015) 0.76
The role of the potassium channel gene KCNK2 in major depressive disorder. Psychiatry Res (2014) 0.76
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients. J Affect Disord (2016) 0.75
Influence of GRIK4 genetic variants on the electroconvulsive therapy response. Neurosci Lett (2016) 0.75